Comparing the current results to its competitors, Sensus Healthcare Inc reported Revenue decrease in the 2 quarter 2026 year on year by -66.83 %, faster than the overall decrease of Sensus Healthcare Inc 's competitors by -2.49 %, recorded in the same quarter.
Sensus Healthcare Inc 's Comment on Competition and Industry Peers
Sensus operates in the competitive and rapidly evolving medical device industry, facing competition from healthcare providers offering alternative treatments for the same conditions. Key factors influencing competition include medical outcomes, acceptance by doctors and patients, ease of use, reliability, pricing, reimbursement eligibility, technical leadership, marketing and distribution effectiveness, speed to market, and client service quality. To manage costs and support inventory ramp-up, Sensus employs third-party manufacturing relationships, including a preferred supplier and Koplak, LLC, which was contracted in 2025 for special projects related to SRT products.
April 25, 2024
Sensus Healthcare s First Quarter 2024 Financial Results Revealed: Promising Growth and Expanding Treatment SolutionsBOCA RATON, Fla., April 25, 2024 - Sensus Healthcare, Inc. (Nasdaq: SRTS), a leading medical device company specializing in innovative non-invasive treatments for both oncological and non-oncological conditions, announced that it will be holding a conference call on Thursday, May 9, 2024, at 4:30 p.m. Eastern time. The call aims to discuss the company s financial results for the first quarter of 2024, as well as provide a comprehensive business update and discuss recent and upcoming milestones.Sensus Healthcare has gained significant recognition in the healthcare industry for its ground-breaki...
Anika Therapeutics Inc is a medical technology company that focuses on developing and commercializing therapeutic products to treat tissue-related disorders. Their business model revolves around conducting extensive research and development to create innovative therapies, partnering with healthcare professionals and distributors to bring their products to market, and generating revenue through the sale of these products worldwide. They also collaborate with other companies and academic institutions to enhance their product portfolio and expand their reach in the healthcare industry.
Becton Dickinson and Company operates a business model focused on developing and providing advanced medical technologies, including a diverse portfolio of medical devices and diagnostic products. Their strategy emphasizes innovation, quality, and strategic partnerships to enhance patient care and streamline healthcare processes across various settings.
Bausch Health Companies Inc operates through three segments: Bausch + Lomb/International, Salix, and Ortho Dermatologics. The company focuses on developing, manufacturing, and marketing a wide range of pharmaceutical products, medical devices, and over-the-counter products primarily in the areas of eye health, gastroenterology, and dermatology. Bausch Health aims to provide innovative and quality healthcare solutions to improve patients' lives globally.
Boston Scientific Corporations business model centers on creating innovative medical devices for diverse specialties, aimed at addressing unmet medical needs and enhancing patient outcomes. The company sells its products to healthcare professionals and hospitals globally, supported by robust sales and distribution networks. It prioritizes research and development to continually introduce new technologies and solutions.
Brainsway Ltd is a medical device company that focuses on developing and commercializing advanced non-invasive treatments for brain disorders. Their business model revolves around the manufacturing and sale of deep transcranial magnetic stimulation (dTMS) systems, which are used in the treatment of major depressive disorder and obsessive-compulsive disorder, among other conditions. Through partnerships with healthcare providers and licensing agreements, Brainsway aims to expand the accessibility and adoption of their innovative technologies worldwide.
Sources:
Sensus Healthcare Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Sensus Healthcare Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
